With $200M in hand, Cambridge startup EQRx sets goal: no blockbuster drugs - Boston Business Journal
Blavatnik $50 million gift Harvard life sciences boosts biomedical discoveries | Harvard Magazine
Alexis Borisy Net Worth | Bio, Family, Address, Career - Bongonote
Alexis Borisy - Curie.Bio | LinkedIn
Alexis Borisy loses majority investor support at Blueprint
Blueprint's Albers hands CEO baton to deal mastermind Haviland after steering 2 cancer drug launches | Fierce Pharma
With $200M in hand, Cambridge startup EQRx sets goal: no blockbuster drugs - Boston Business Journal
Alexis Borisy | MIT Technology Review
Alexis Borisy - Co-Founder @ Idrx - Crunchbase Person Profile
Leon 'Jun' T. on LinkedIn: Updated: EQRx acquired by Revolution Medicines, another Alexis Borisy… | 26 comments
Leon 'Jun' T. on LinkedIn: Updated: EQRx acquired by Revolution Medicines, another Alexis Borisy… | 26 comments
Third Rock Ventures: Giving birth to a new generation of biotechs
EQRx's Alexis Borisy Interview on Geopolitics, Low-Drug-Prices Pledge
EQRx sells to another Alexis Borisy biotech after multiple pivots - Boston Business Journal
Endpoints News — EQRx abandons its mission of drug price reforms; Baxter offloads biopharma biz for $4B+
With $200M in hand, Cambridge startup EQRx sets goal: no blockbuster drugs - Boston Business Journal
EQRx's Alexis Borisy Interview on Geopolitics, Low-Drug-Prices Pledge
Alexis Borisy – Relay Therapeutics
Alexis Borisy and Co. Raise $520M for New Model VC | BioSpace
BI 100: the Creators - Business Visionaries Creating Value for the World
